BRIEF published on 11/18/2024 at 23:05, 1 year 5 months ago Medicure présentera ses résultats financiers du troisième trimestre 2024 dans un contexte de changements au sein du conseil d'administration Résultats Financiers Conférence Téléphonique Démission Du Conseil D'administration Medicure 3e Trimestre 2024
BRIEF published on 11/18/2024 at 22:10, 1 year 5 months ago Protagonist Therapeutics Reports Positive Phase 3 Trial Results for Icotrokinra in Psoriasis Phase 3 Trials Protagonist Therapeutics Johnson & Johnson Plaque Psoriasis Icotrokinra
BRIEF published on 11/18/2024 at 22:10, 1 year 5 months ago Protagonist Therapeutics annonce des résultats positifs de l'essai de phase 3 sur l'icotrokinra dans le traitement du psoriasis Essais De Phase 3 Thérapeutique Protagoniste Johnson & Johnson Icotrokinra Psoriasis En Plaques
BRIEF published on 11/18/2024 at 21:50, 1 year 5 months ago Torq Resources Extends Financing Offer Period TSX Venture Exchange Exploration Projects Chile Torq Resources Financing Extension
BRIEF published on 11/18/2024 at 21:50, 1 year 5 months ago Torq Resources prolonge la période de son offre de financement Bourse De Croissance TSX Projets D'exploration Chili Prolongation Du Financement Ressources Torq
BRIEF published on 11/18/2024 at 20:55, 1 year 5 months ago Tableau de Suivi des Exercices de BSA 2023-RY chez GAUSSIN Investisseurs Bons De Souscription GAUSSIN Exercice BSA Actions Souscrites
BRIEF published on 11/18/2024 at 20:55, 1 year 5 months ago BSA 2023-RY Exercise Monitoring Table at GAUSSIN Investors Warrants GAUSSIN BSA Exercise Shares Subscribed
BRIEF published on 11/18/2024 at 20:55, 1 year 5 months ago GAUSSIN S.A. : État des BSA 2023-RY au 18 novembre 2024 Investissement Actions Transport GAUSSIN BSA
BRIEF published on 11/18/2024 at 20:55, 1 year 5 months ago GAUSSIN SA: Status of BSA 2023-RY as of November 18, 2024 Actions Investment Transportation GAUSSIN BSA
BRIEF published on 11/18/2024 at 20:17, 1 year 5 months ago Aap Implantate AG Raises EBITDA Forecast EBITDA Profitability Forecast Trauma Business Silver Technology
Published on 04/21/2026 at 00:00, 50 minutes ago LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
Published on 04/20/2026 at 22:15, 2 hours 35 minutes ago Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders
Published on 04/20/2026 at 15:25, 9 hours 25 minutes ago Banyan Gold Announces $46.5 Million Private Placement
Published on 04/20/2026 at 14:30, 10 hours 20 minutes ago Biomind Labs Applauds Landmark Executive Order Accelerating Psychedelic Research and Access in The United States
Published on 04/20/2026 at 22:05, 2 hours 44 minutes ago Abivax assemblée générale ordinaire annuelle et extraordinaire du 11 mai 2026 - Mise à disposition des documents préparatoires
Published on 04/20/2026 at 22:05, 2 hours 44 minutes ago Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
Published on 04/20/2026 at 19:00, 5 hours 49 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 13 avril 2026 au 17 avril 2026
Published on 04/20/2026 at 18:59, 5 hours 50 minutes ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback
Published on 04/20/2026 at 18:59, 5 hours 50 minutes ago EQS-Adhoc: Fabasoft AG: Fabasoft AG resolves share buyback
Published on 04/20/2026 at 20:44, 4 hours 5 minutes ago ENGIE - Implementation of share buyback programme
Published on 04/20/2026 at 20:44, 4 hours 5 minutes ago ENGIE - Mise en œuvre de son programme de rachat d'actions
Published on 04/20/2026 at 20:01, 4 hours 48 minutes ago TERACT - Approval by the AMF of the public buy out offer followed by a squeeze-out of TERACT shares
Published on 04/20/2026 at 20:01, 4 hours 48 minutes ago TERACT - Communiqué TERACT mise à disposition NR et DAI
Published on 04/20/2026 at 20:01, 4 hours 48 minutes ago TERACT - Approbation par l’AMF de l’offre publique de retrait suivie d’un retrait obligatoire sur les titres de TERACT
